High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer

• Published in: BMC urology Vol. 23; no. 1; p. 37
• Main Authors: Fan, JiaWen, Ding, Yi, Huang, HaoXuan, Xiong, ShiDa, He, Liang, Guo, Ju
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 17.03.2023; BioMed Central; BMC
• Subjects: ABC transporters; ABCF1; Antibodies; ATP-Binding Cassette Transporters - metabolism; BCG; BCG vaccines; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Biosynthesis; Bladder cancer; Cancer; Cell Line; Chemotherapy; Gene expression; GSEA; Health aspects; Humans; Medical prognosis; Membranes; Polymerase chain reaction; Prognosis; Protein synthesis; Proteins; Stem cells; Surgery; Therapeutic targets; Tumors; Urinary Bladder Neoplasms - pathology; Urology; Western blotting; China; Beijing China; GSEA; Prognosis; Bladder cancer; ABCF1
• ISSN: 1471-2490; 1471-2490
• DOI: 10.1186/s12894-023-01211-y

ABCF1, a member of the ATP-binding cassette (ABC) transporter family, is involved in the malignant progression of tumors. However, the role of ABCF1 in bladder cancer is poorly understood. In our study, we explored the differential expression of ABCF1 in bladder cancer and normal bladder tissues based on bioinformatic analysis and immunohistochemical results. GSEA was performed to ascertain the potential related signaling pathways of ABCF1. The relationship between ABCF1 expression and bladder cancer progression was analyzed using the GSE13507 dataset. In addition, the differential expression of ABCF1 in the cell lines was verified by quantitative real-time polymerase chain reaction (qRT‒PCR) and Western blotting. ABCF1 was upregulated in bladder cancer, and the high expression of ABCF1 was closely related to sex (P = 0.00056), grade (P = 0.00049), T stage (P = 0.00007), and N stage (P = 0.0076). High expression of ABCF1 was correlated with poor overall survival in bladder cancer patients (P < 0.001). In addition, univariate and multivariate Cox regression analyses showed that high ABCF1 expression was an independent factor for poor prognosis in bladder cancer patients. Therefore, ABCF1 expression is closely related to the progression of bladder cancer and can be used as a potential indicator of poor prognosis and a therapeutic target for bladder cancer.